• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 5. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431

Research Brief on 2,2-Difluoro-1-(1H-indol-7-yl)ethan-1-ol (CAS: 2229525-19-1): Recent Advances and Applications

The compound 2,2-difluoro-1-(1H-indol-7-yl)ethan-1-ol (CAS: 2229525-19-1) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural features and potential therapeutic applications. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and emerging applications in drug discovery.

Recent studies have highlighted the synthetic versatility of 2,2-difluoro-1-(1H-indol-7-yl)ethan-1-ol as a key intermediate in the development of novel indole-based fluorinated compounds. Indole derivatives are well-known for their broad pharmacological activities, including anticancer, antimicrobial, and anti-inflammatory properties. The incorporation of difluoroethanol moiety at the 7-position of the indole ring enhances the compound's metabolic stability and bioavailability, making it a promising candidate for further optimization.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers demonstrated the efficient synthesis of 2,2-difluoro-1-(1H-indol-7-yl)ethan-1-ol via a palladium-catalyzed cross-coupling reaction, achieving high yields and excellent regioselectivity. The compound was further evaluated for its inhibitory activity against a panel of kinases implicated in cancer progression. Preliminary results indicated moderate to strong inhibition of specific kinase targets, suggesting its potential as a scaffold for kinase inhibitor development.

Another notable application of this compound lies in its role as a precursor for the synthesis of fluorinated analogs of natural products. A recent publication in Organic Letters detailed the use of 2,2-difluoro-1-(1H-indol-7-yl)ethan-1-ol in the total synthesis of a fluorinated version of a marine-derived indole alkaloid, which exhibited enhanced cytotoxic activity against drug-resistant cancer cell lines compared to its non-fluorinated counterpart.

From a mechanistic perspective, computational studies have provided insights into the electronic effects of the difluoroethanol group on the indole core. Density functional theory (DFT) calculations revealed that this substitution pattern significantly influences the compound's binding affinity to biological targets, particularly through favorable electrostatic interactions with key amino acid residues in enzyme active sites.

Ongoing research is exploring the potential of 2,2-difluoro-1-(1H-indol-7-yl)ethan-1-ol in the development of positron emission tomography (PET) tracers, leveraging the fluorine atoms for ¹⁸F-labeling. This application could provide valuable tools for imaging studies in neurological disorders and oncology.

In conclusion, 2,2-difluoro-1-(1H-indol-7-yl)ethan-1-ol represents a versatile building block in medicinal chemistry with multiple potential applications. Its unique structural features, combined with recent synthetic advances and promising biological activities, position this compound as an important focus for future drug discovery efforts. Further studies are warranted to fully explore its therapeutic potential and optimize its pharmacological properties.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)